Key points are not available for this paper at this time.
A given molecular structure can lead to more than one crystallized form, a phenomenon known as polymorphism. As discussed in the Perspective by Desiraju, polymorphism is an important scientific and technological question as more effort is brought to bear on the problem of designing materials. Moreover, polymorphism can have legal ramifications, as demonstrated in the litigation surrounding the ulcer drug Zantac.
Gautam R. Desiraju (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: